On This Page – Quick Medical Summary
What the 2026 guidelines actually restored
In March 2026, the new cholesterol guidelines brought back something the previous version set aside: specific LDL numbers to treat toward. Which one applies to you is decided by your risk of a heart attack or stroke — not by the number printed on your lipid panel.
That distinction is why this page exists. Most coverage reports the numbers; less of it reports the conditions attached to them.
The goals apply to LDL and non-HDL cholesterol, neither of which is measured directly — both are worked out from the values a panel reports.
ℹ️ Medical Disclaimer: This article explains published clinical guidance. It does not diagnose any condition, assign you a risk category, or recommend any treatment, medication, procedure, or insurance decision — those are set for individual patients by a licensed clinician who knows your history. Consult a board-certified cardiologist or your primary care physician before acting on anything here.
What actually changed in the 2026 cholesterol guidelines
The 2026 guideline on the management of dyslipidemia retires and replaces the 2018 blood cholesterol guideline. It was issued on 13 March 2026 by the American College of Cardiology, the American Heart Association and nine other associations.
Treatment goals returned, and percent reduction stayed
The headline change is that LDL and non-HDL cholesterol treatment goals are back to guide lipid-lowering therapy. Percentage reduction did not go away. Both sit side by side, and how far your number should fall depends on your risk, as set out in the announcement of the 2026 guideline.
A new risk calculator replaced the old one
For people without known heart disease, the guideline moved to the PREVENT-ASCVD equations instead of the older Pooled Cohort Equations. These estimate 10-year and 30-year risk in adults aged 30 to 79.
What did not change
The published desirable levels on federal patient pages were not rewritten. The same guideline also changed when adult cholesterol screening starts, which is a separate question from what your number should be.
The new LDL goals, and who each one belongs to
Four groups have a published LDL goal. The right-hand column is what most coverage leaves out.
| Who this describes | LDL-C goal | What has to be true before this goal is yours |
|---|---|---|
| You have atherosclerotic cardiovascular disease and are at very high risk of another event | Below 55 mg/dL | A clinician has established you have ASCVD and placed you in the very-high-risk group |
| You have ASCVD but are not in the very-high-risk group | Below 70 mg/dL | The same diagnosis, without the very-high-risk assessment |
| No known ASCVD, estimated 10-year risk is high | Below 70 mg/dL | A clinician has run the risk estimate and it came out at 10% or higher |
| No known ASCVD, estimated risk is borderline or intermediate | Below 100 mg/dL | The same estimate, falling between 3% and under 10%, with treatment being decided |
Goals as published in the American Heart Association’s summary of the 2026 guideline and its news release. The right-hand column is this article’s summary of the conditions each goal carries — not a set of categories published by the guideline.
If you have had a heart attack or stroke
The lowest goal belongs to people with established ASCVD at very high risk of another event. A smaller number with ASCVD sit outside that group, but the guideline states that most people with a history of such events will likely qualify for the lower figure.
🔬 How It Works: Response to treatment is judged two ways at once — how far the number has fallen from where it started, and whether it has reached the absolute goal for your group. That is why a large drop can still leave someone short of their goal.
If your estimated risk is borderline or intermediate
This is the row that gets misquoted. The 100 mg/dL figure is not a new definition of normal — it belongs to people at borderline or intermediate estimated risk, in the context of a treatment decision. Any coronary artery calcium found on a scan also supports a goal below 100 mg/dL, with lower targets at higher amounts, per the AHA’s summary of the 2026 guideline.
The non-HDL companion goal
Non-HDL cholesterol has goals too. The one published for the very-high-risk group is below 85 mg/dL, beside the LDL figure in the same row. Understanding what the non-HDL number is comes before comparing it to anything.
How your risk level gets decided
Every goal above depends on a risk level, and a risk level is not something you can read off a lipid panel. It is an estimate a clinician produces from information collected at a routine physical — cholesterol values, blood pressure, age and health habits.
What the new calculator uses and who it was built for
The equations were designed for adults aged 30 to 79 without known cardiovascular disease or subclinical atherosclerosis, whose LDL cholesterol sits between 70 and 189 mg/dL. Outside that window, they are not what this framework was built on.
📊 Clinical Data Point: The older Pooled Cohort Equations overestimated 10-year heart attack and stroke risk by 40%–50% — Source: American Heart Association news release, March 2026, attributed to the guideline writing committee chair.
What can move your estimate
The estimate is then personalised using risk enhancers: family history, chronic inflammatory conditions, cardiometabolic conditions such as the cluster of findings behind metabolic syndrome, ancestry, and reproductive risk markers.
After age 75
For adults aged 40 to 75 with diabetes, chronic kidney disease stage 3 or 4, or HIV, lipid-lowering therapy is recommended whatever the LDL level. After 75, the guideline says it can be considered alongside lifestyle measures rather than recommending it outright.
A goal is not the same as a normal range
If you are holding a report and trying to work out whether you have failed something, this is the section that matters. A treatment goal and a normal range are different kinds of number, and they can share the same digits.
Why the same number can mean two things
A published desirable level describes what is generally considered healthy for adults; a treatment goal describes what treatment aims to achieve in one risk group, so it exists only once someone has established which group you are in. MedlinePlus notes that newer guidance steered clinicians away from specific LDL targets while some still use them, and that the ideal values for all cholesterol results depend on your own conditions and risk factors. The two-kinds-of-number reading here is this article’s own.
What a gap between the two does not mean
A result above one of the figures in Section 3 does not by itself establish a diagnosis, a risk level, or a need for treatment. Nor does a result below one clear you, if no clinician has assigned you that goal. See what a flagged lipid result means and how a normal range, a desirable level and a goal differ.
⚠️ Clinical Warning: Do not start, stop, or change any cholesterol medicine because a number on your report sits above or below a goal you found online. Treatment goals are assigned to patients, not to results — and stopping prescribed therapy after reading a reassuring number is the specific risk this page carries.
What the guidelines did not set a goal for
Restoring LDL goals raises an obvious question about the other lines on your report. For most, no equivalent treatment target was set.
HDL is still not a treatment target
According to how the AHA describes each cholesterol value, HDL cholesterol is not a treatment target and should not be interpreted on its own. That is worth knowing before hunting for an HDL goal that does not exist. What moves the number is covered in why HDL is read differently.
Triglycerides are handled differently
Triglycerides are also not a primary treatment target. Where they stay persistently elevated, medication remains the foundation alongside lifestyle measures, and which one is a question for your clinician. The causes behind a raised triglyceride number are covered separately.
The extra tests you may have read about
Two other measurements appeared in coverage of the guideline. Lipoprotein(a) is now recommended to be measured at least once in adulthood. Apolipoprotein B can be useful once the LDL and non-HDL goals are met, as a way of finding risk the standard panel underestimates.
What to do with this before your next appointment
The useful outcome is not a number you decided applies to you. It is a short list to raise with someone who can assign you a risk group.
Three things worth bringing
- Your most recent lipid panel, with the date it was drawn.
- Any heart attack or stroke early in life among immediate family.
- Any of the conditions named in Section 4 that apply to you.
The plain-language summary written for patients, published by the American Heart Association alongside the guideline, is worth reading before you go.
What not to conclude on your own
A number on its own does not establish which group you are in, and a gap between your result and one of the figures above is a conversation, not a diagnosis. If your result came back high, what usually happens in the first month will help more than any goal here.
✅ Patient Action: Ask your primary care physician — or your cardiologist, if you have had a heart attack or stroke — this question directly: “Under the 2026 guideline, which risk group am I in, and which LDL goal applies to me?”
Common questions about the new cholesterol guidelines
1. Did the LDL target change for everyone?
No — the new cholesterol guidelines restored LDL goals for four defined groups, each tied to a level of cardiovascular risk or to established heart disease. People who fall into none of those groups were not given a new number to meet. Which group applies to you is something a clinician determines, so ask at your next appointment rather than assuming a goal applies to you.
2. How do I know which risk level I am in?
You cannot work it out from a lipid panel alone. Under the new cholesterol guidelines, the estimate combines cholesterol values with blood pressure, age and health habits, and it is then adjusted for risk enhancers such as family history. A clinician runs that calculation and interprets the result, which is the conversation worth having at your next visit.
3. Do the new goals mean I need medicine?
Not on their own — the new cholesterol guidelines set goals to guide lipid-lowering therapy once a clinician has established that treatment is appropriate, and lifestyle measures remain part of that discussion. A result above one of the published figures is a reason to ask about your risk level, rather than evidence that treatment has already been decided for you. Discuss any medication change with the clinician who prescribed it.
What the new cholesterol guidelines mean for your report
The change that matters is smaller and more specific than the headlines suggest. LDL and non-HDL treatment goals came back, tiered by cardiovascular risk, and the tier is assigned by a clinician using information your lipid panel does not contain. That is why the same figure can be a treatment goal for one person and a published desirable level for another.
See how your lipid panel is put together, then take the report and the question in Section 7 to someone who can answer it.
About this content
How this article was put together: researched from recognised health sources, drafted with the help of AI tools, and edited by hand, with sources linked throughout.
Sameer Patel is the founder and editor of My Medicine Advisor. He is not a doctor or medical professional — before starting this site he worked in banking,…
Medical disclaimer
The content on MyMedicineAdvisor is provided for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Health information on this website should not be used to diagnose, treat, cure, or prevent any condition without guidance from a qualified healthcare professional. Always seek the advice of your doctor, physician, or another licensed healthcare provider with any questions you may have regarding a medical condition, symptoms, medications, or treatment decisions.
